Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tyra Biosciences, Inc.

10.86
+0.38003.63%
Post-market: 10.860.00000.00%16:25 EDT
Volume:394.24K
Turnover:4.29M
Market Cap:576.56M
PE:-7.19
High:10.99
Open:10.60
Low:10.48
Close:10.48
Loading ...
Oct 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2024

Major Issues Report

Form 8-K - Current report
Oct 25, 2024

Major Issues Report

Form 8-K - Current report
Oct 22, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 22, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 18, 2024

Major Issues Report

Form 8-K - Current report
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]